ArticleHealth science reports2025
Predictors of Poor Pneumonia Outcomes in Older Adults: A Multicentered Follow-Up Study.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Characteristics and Outcomes of Carbapenem-Resistant Gram-Negative Bacteria Pneumonia in Immunocompromised ICU Patients: A Retrospective Study.Infection and drug resistance · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Severe pneumonia is a leading cause of mortality among older adults, particularly in low-income countries like Ethiopia. Despite treatment advancements, the role of different factors in predicting poor outcomes remains understudied. This study aims to assess early indicators poor outcomes in severe pneumonia among older adults. Methods: A multicenter retrospective cohort study was conducted involving 422 older adults aged over 65 years. Kaplan-Meier survival curves and log-rank tests were utilized to compare survival across categories. Cox regression analysis was performed to evaluate the association between these factors and poor outcomes, while adjusting for potential confounders. Results: Of the patients, 13.27% (95% CI: 10.18, 16.88) died from severe pneumonia. CHF (AHR = 2.35, 95% CI: 1.23, 4.49), DM (AHR = 2.52, 95% CI: 1.23, 5.14), and COPD (AHR = 2.59, 95% CI: 1.39, 4.81), elevated creatinine (AHR = 1.63, 95% CI: 1.63, 2.69), and low platelet count (AHR = 2.43, 95% CI: 1.78, 5.34) were significantly associated with poor outcomes. Conclusion: Thrombocytopenia and high creatinine levels may serve as early indicators of poor outcomes in severe pneumonia among older adults. Monitoring these markers is critical for guiding interventions and improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.